Dulac Edward J III

Track

Insider profile

Performance

Overall performance
3.9
Performance over holding periods
3.9
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 75% 68% 82%
Transactions
13 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dulac Edward J III's trades of Intellia Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
263.44
Quantity 35,853
Value US$2,502,707
Transaction date
Proposed sale
Price
7.77
Quantity 2,447
Value US$19,013
Transaction date
Proposed sale
Price
5.00
Quantity 1,849
Value US$9,245
Transaction date
Proposed sale
Price
4.37
Quantity 7,028
Value US$30,692
Transaction date
Proposed sale
Price
3.66
Quantity 5,182
Value US$18,966
Transaction date
Proposed sale
Price
3.50
Quantity 1,585
Value US$5,548
Transaction date
Proposed sale
Price
2.80
Quantity 4,718
Value US$13,231
Transaction date
Proposed sale
Price
4.83
Quantity 5,182
Value US$25,029
Transaction date
Planned sale
Price
60.00
Quantity 15,977 -12.6%
Value US$958,620
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-24 2026-07-22
S Sale
17,767 +36.8%
281.07
US$972,654 		17,767 +36.8% 281.07 US$972,654
2026-07-06 2026-07-02
PlS Planned sale
52,757 +39.8%
195.14
US$3,320,071 		52,757 +39.8% 195.14 US$3,320,071
2026-07-02 2026-07-02
PrS Proposed sale
35,853
263.44
US$2,502,707 		35,853 263.44 US$2,502,707
2026-01-07 2026-01-05
S Sale
6,379 -6.0%
9.21
US$58,751 		6,379 -6.0% 9.21 US$58,751
2025-07-25 2025-07-23
S Sale
7,462 -6.6%
14.02
US$104,617 		7,462 -6.6% 14.02 US$104,617
2024-03-05 2024-03-04
PlS Planned sale
2,447 -2.4%
7.77
US$19,013 		2,447 -2.4% 7.77 US$19,013
2024-03-04 2024-03-04
PrS Proposed sale
2,447
7.77
US$19,013 		2,447 7.77 US$19,013
2024-01-30 2024-01-29
PlS Planned sale
1,849 -1.7%
5.00
US$9,245 		1,849 -1.7% 5.00 US$9,245
2024-01-29 2024-01-29
PrS Proposed sale
1,849
5.00
US$9,245 		1,849 5.00 US$9,245
2024-01-10 2024-01-09
S Sale
7,028 -6.2%
4.37
US$30,712 		7,028 -6.2% 4.37 US$30,712
2024-01-09 2024-01-09
PrS Proposed sale
7,028
4.37
US$30,692 		7,028 4.37 US$30,692
2024-01-03 2024-01-02
PlS Planned sale
5,182 -4.4%
3.66
US$18,966 		5,182 -4.4% 3.66 US$18,966
2024-01-02 2024-01-02
PrS Proposed sale
5,182
3.66
US$18,966 		5,182 3.66 US$18,966
2023-12-19 2023-12-18
PlS Planned sale
1,585 -1.3%
3.50
US$5,548 		1,585 -1.3% 3.50 US$5,548
2023-12-18 2023-12-18
PrS Proposed sale
1,585
3.50
US$5,548 		1,585 3.50 US$5,548
2023-08-21 2023-08-18
S Sale
4,718 -3.8%
2.80
US$13,210 		4,718 -3.8% 2.80 US$13,210
2023-08-18 2023-08-18
PrS Proposed sale
4,718
2.80
US$13,231 		4,718 2.80 US$13,231
2023-07-06 2023-07-05
PlS Planned sale
5,182 -4.0%
4.83
US$25,029 		5,182 -4.0% 4.83 US$25,029
2023-07-05 2023-07-05
PrS Proposed sale
5,182
4.83
US$25,029 		5,182 4.83 US$25,029
2023-01-11 2023-01-10
S Sale
7,331 -5.4%
5.24
US$38,414 		7,331 -5.4% 5.24 US$38,414
2022-08-19 2022-08-18
S Sale
432 -0.3%
30.41
US$13,137 		432 -0.3% 30.41 US$13,137
2022-08-19 2022-08-18
S Sale
4,703 -3.3%
29.75
US$139,914 		4,703 -3.3% 29.75 US$139,914
2022-01-13 2022-01-11
S Sale
390 -0.4%
49.16
US$19,172 		390 -0.4% 49.16 US$19,172
2022-01-13 2022-01-11
S Sale
1,380 -1.2%
48.25
US$66,585 		1,380 -1.2% 48.25 US$66,585
2021-12-21 2021-12-20
PlS Planned sale
15,977 -12.6%
60.00
US$958,620 		15,977 -12.6% 60.00 US$958,620
2021-08-20 2021-08-19
S Sale
63 -0.1%
90.00
US$5,670 		63 -0.1% 90.00 US$5,670
2021-08-20 2021-08-19
S Sale
1,474 -2.6%
88.65
US$130,670 		1,474 -2.6% 88.65 US$130,670
2021-08-20 2021-08-19
S Sale
1,937 -3.3%
87.90
US$170,262 		1,937 -3.3% 87.90 US$170,262